Delivery Order SPE2DB22D3501-SPE2DB25FXH72
Award Date 9/15/25
Potential Completion Date 9/16/25
Potential Value $2.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $1,561.45 to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Clindamycin 900 mg/50 mL in 5% dextrose solution (50 mL units). This firm fixed price, competitively awarded delivery order is set to be completed by July 31, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,978.65 for Clindamycin 900 mg/50 ml in dextrose 5% water solution on June 4, 2025, with completion scheduled for June 5, 2025. This firm fixed-price contract, awarded without set-aside designation through competitive procedures, represents a child delivery order issued against AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The product will be delivered...
- The Defense Logistics Agency awarded a delivery order valued at $1,259.64 to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Clindamycin 900 mg/50 ml in Dextrose 5% Water solution. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 5, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting the competitive nature of the procurement. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Clindamycin PH 1% Solution in 60ML units, with a contract value of $5,685.56. This non-competitive delivery order was awarded on September 24, 2025, with an ultimate completion date of September 25, 2025, and is structured as a firm fixed price contract. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this order at its corporate office location. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,235.36 to AmerisourceBergen Drug Corp for the supply of Clindamycin 900 mg/50 ml in D5W solution on August 4, 2025, with completion scheduled for August 5, 2025. This non-competitive delivery order represents a firm fixed price transaction executed under AmerisourceBergen's Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999 and extending...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Clindamycin PH 900 mg/6 ml vials on June 17, 2025, with a ceiling value of $1,347.33. This is a firm fixed-price delivery order with an ultimate completion date of June 18, 2025, reflecting the time-sensitive nature of pharmaceutical procurement for military and federal healthcare operations. The contract carries no set-aside designation, indicating it was awarded...
- The Defense Logistics Agency awarded a delivery order valued at $4,495.87 to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Clindamycin HCL 150 mg capsules (100-count units). This is a firm fixed-price delivery order with an ultimate completion date of August 7, 2025, and represents a non-competitive set-aside award. The product will be supplied from AmerisourceBergen's Conshohocken, Pennsylvania facility, where the company maintains its corporate headquarters. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,383.77 to AmerisourceBergen Drug Corp for Clindamycin 900 mg/50 mL in D5W solution on June 18, 2025, with an ultimate completion date of June 20, 2025. This delivery order is competitively awarded with no set-aside designation and employs firm fixed price terms. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and...
- The Defense Logistics Agency awarded a delivery order valued at $1,042.56 to AmerisourceBergen Drug Corp for Clindamycin PH 1% Solution in 60ml quantities. The contract is a firm fixed price delivery order with an ultimate completion date of September 22, 2025, and was awarded on September 19, 2025. No set-aside designation was used in this competitive award. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,234.84 to AmerisourceBergen Drug Corp for the supply of Clindamycin 900 mg/50 mL in 50 mL vials. This is a firm fixed price delivery order with an ultimate completion date of September 29, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly...